New Blood Biomarker Outperforms Traditional Tests in Predicting Long-Term Brain Injury Following Cardiac Arrest

New research from ESC 2026 shows neurofilament light chain is a superior biomarker for predicting long-term cognitive function in cardiac arrest survivors.

By: AXL Media

Published: Mar 23, 2026, 6:02 AM EDT

Source: Information for this report was sourced from European Society of Cardiology

The Search for Precision in Neurological Prognostication

Clinicians have long struggled to accurately forecast the extent of brain damage in patients who remain comatose following an out-of-hospital cardiac arrest. While current protocols rely on a variety of scans and bedside tests, the immediate aftermath of such a trauma is often clouded by biological variables that make long-term predictions difficult. The emergence of neurofilament light chain as a measurable blood biomarker offers a potential shift toward more precise, data-driven neurology. By identifying the specific proteins released during neural injury, medical teams can gain a clearer understanding of a patient's recovery trajectory while they are still in the acute phase of hospital admission.

Challenging the Reliability of Current Clinical Standards

The study specifically compared the diagnostic performance of the emerging neurofilament marker against the long-standing industry standard, neuron-specific enolase. According to Doctor Martin Meyer of Rigshospitalet, there have been growing concerns regarding the reliability of enolase, as several factors unrelated to brain injury can artificially inflate its levels in the bloodstream. By analyzing samples from the BOX trial, the research team found that while enolase provided an inconsistent picture of recovery, the neurofilament light chain maintained a direct and reliable link to the patient's eventual cognitive health, marking a significant improvement over traditional methods.

Evidence of Lasting Impact on Cognitive Function

The investigation’s primary finding centered on the inverse correlation between early protein levels and subsequent mental performance scores. Patients who exhibited higher concentrations of neurofilament light chain 48 hours after their cardiac event consistently achieved lower scores on the Montreal Cognitive Assessment months later. This early spike in the bloodstream serves as a biological footprint of the severity of the initial brain injury, allowing doctors to identify high-risk individuals long before they regain consciousness or attempt to perform complex cognitive tasks.